Robert John Fontana, MD
To request an appointment call
Manage Your Profile
About
Dr. Fontana is a Professor of Medicine and Director of the Transplant Hepatology Fellowship Program. He is recognized as a national and international expert in managing patients with cirrhosis, portal hypertension and nearly all forms of acute and chronic liver disease. He has particular research interest in patients with drug induced liver injury, viral hepatitis, and genetic liver disease.
Areas of Practice
Expertise
Locations
-
Medical Procedure Center | East Ann Arbor Ambulatory Surgery & Medical Procedures Center 4270 Plymouth Rd
Entrance 4
Ann Arbor, MI 48109-2700Get Directions -
Medical Procedures Unit | Brighton Center for Specialty Care 7500 Challis Rd
Entrance 2, Level 1
Brighton, MI 48116-9416Get Directions -
Hepatology Clinic | Taubman Center 1500 E Medical Center Dr
Floor 3 Reception D
Ann Arbor, MI 48109-2435Get Directions -
Transplant Clinic | Taubman Center 1500 E Medical Center Dr
Floor 1 Reception G
Ann Arbor, MI 48109-5334Get Directions -
Medical Procedures Unit | University Hospital 1500 E Medical Center Dr
Floor 2
Ann Arbor, MI 48109-5051Get Directions -
Medical Procedures Services| Northville Health Center 39901 Traditions Dr
Floor 1
Northville, MI 48168-9493Get Directions -
Liver Transplant Clinic | UM Health-Sparrow Professional Building 1200 E Michigan Avenue
Lansing, MI 48912Get Directions
Insurance Accepted
University of Michigan Health participates with most health insurance plans.
Education & Training
Medical School or Training
Residency
Fellowships
Board Certifications
Professional Organizations
Research Overview
Dr. Fontana has conducted studies on the treatment and management of patients with chronic Hepatitis C and B viral infeciton. He has also conducted studies on evaluation of patients with cirrhosis including the develpoment of non-invasive biomarkers of disesae severity. As Medical Director of the Liver Transplantation program for over 20 years he also conducted important studies on the use of antiviral medications before and after liver transplantation as well as studies to optimize the selection of candidates for transplantation including critically ill patients with acute liver failure and those requiring a TIPS placement for complications of portal hypertension. He currently has active studies exploring genetic and clinical risk factors for patients with idiosyncratic Drug Induced Liver injury as part of the NIH sponsored DILIN network. In this study, he works with over 200 practicioners in Michigan to enroll patients with DILI into an ongoing registry study and is making great progress in developing a blood based diagnostic biomarker for DILI diagnosis.
Links
Patient Ratings & Comments
Visit our Physician Ratings & Comments page to learn more about how patient ratings are collected, calculated, and updated to help you make an informed decision when choosing the right physician for your care.
Patient Ratings
219 Patient Ratings
Patient Comments
June 25, 2026 - "Dr Fontana spent time asking questions, explaining his thoughts and plans. This visit was the most informative, pleasant, thoughtful, respectful and comforting I have ever had."
June 20, 2026 - "Dr. Fontana is awesome! I've been seeing him since [...]. He's such a great doctor with a very pleasant, calming personality."
June 16, 2026 - "[...] Dr. Fontana lacked bedside manner, ability to listen well, hear my concerns as a new mother, debated with me about my level of pain, provided no education on chronic disease or pain [...]"
April 30, 2026 - "Dr Fontana has been the only consistantly good experience I have had at U of M"
April 17, 2026 - "Dr. Fontana is an excellent physician."
March 21, 2026 - "Dr Fontana has always been the very best."
February 26, 2026 - "I have know Dr. Fontana for decades and hope to stay with him until he retires"
February 25, 2026 - "Dr. Fontana has an excellent "bedside manner." His statements/comments are clear, concise, firm yet kind and calm. [...]"
February 9, 2026 - "DR Fontana was informative when I asked question [...]"
January 31, 2026 - "I highly respect Dr. Fontana, he is very thorough and I trust his judgment."
Featured News & Stories
Evolving causes, diagnosis of drug-induced liver injury
What to know about a benign liver cyst on your imaging results
New metric better predicts which drug-induced liver injury patients require transplant
How do GLP-1 weight loss drugs affect the liver?